Skip to main content
Top
Published in: Clinical Rheumatology 6/2005

01-12-2005 | Original Article

Arterial occlusion in systemic lupus erythematosus: a good prognostic sign?

Authors: Maria Cristina Baquero Teixeira da Rocha, Maria José Pereira Vilar, Eutília Andrade Medeiros Freire, Mittermayer Barreto Santiago

Published in: Clinical Rheumatology | Issue 6/2005

Login to get access

Abstract

Arterial occlusion with subsequent amputation of extremities is a rare manifestation of systemic lupus erythematosus (SLE). It may be caused by local arteritis and/or thrombosis. We describe the clinical and laboratory manifestations and treatment administered to six SLE patients who developed peripheral arterial necrosis necessitating amputation of extremities secondary to the arterial occlusion. All patients were female, with ages ranging from 16 to 65 years. Arterial occlusion took place in the initial months of disease (median: 7 months). Only one of five patients tested for antiphospholipid antibodies had these antibodies who also had vasculitis and thrombosis in a histopathological study. Most patients presented a very benign outcome after the amputation of extremities and stayed in remission for several years. The satisfactory outcome of most patients after the vascular phenomenon allows us to consider the possibility that such a complication could be, for unknown reasons, a marker for good prognosis in SLE or, alternatively, that the aggressive therapy administrated for patients with this complication at the beginning of the disease could recover the balance of the immune system, avoiding future relapses.
Literature
1.
go back to reference Jindal BK, Martin MFR, Gayner A (1983) Gangrene developing after minor surgery in a patient with undiagnosed systemic lupus erythematosus and anticoagulant. Ann Rheumatol Dis 42:347–349 Jindal BK, Martin MFR, Gayner A (1983) Gangrene developing after minor surgery in a patient with undiagnosed systemic lupus erythematosus and anticoagulant. Ann Rheumatol Dis 42:347–349
2.
go back to reference Kaufman JL, Bancilla E, Slade J (1986) Lupus vasculitis with tibial artery thrombosis and gangrene (letter). Arthritis Rheum 19:1291–1292 Kaufman JL, Bancilla E, Slade J (1986) Lupus vasculitis with tibial artery thrombosis and gangrene (letter). Arthritis Rheum 19:1291–1292
3.
go back to reference Klumb EM, Lederman R, Guimarães SJ, Goldfarb M, Assad JEM, Leite N (1993) Large vessel vasculitis and occlusion associated to antiphospholipid antibodies in systemic lupus erythematosus. Rev Bras Rheumatol 33:42–45 Klumb EM, Lederman R, Guimarães SJ, Goldfarb M, Assad JEM, Leite N (1993) Large vessel vasculitis and occlusion associated to antiphospholipid antibodies in systemic lupus erythematosus. Rev Bras Rheumatol 33:42–45
4.
go back to reference Shaffer B, James GW, Scully JP, Pillsbury DM (1951) Systemic lupus erythematosus. Some cutaneous manifestations related to the diffuse collagenous diseases. Am J Med Sci 221:314–318PubMed Shaffer B, James GW, Scully JP, Pillsbury DM (1951) Systemic lupus erythematosus. Some cutaneous manifestations related to the diffuse collagenous diseases. Am J Med Sci 221:314–318PubMed
5.
go back to reference Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMed Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMed
6.
go back to reference Wilson WA, Gharavi AE, Koike T et al (1999) International consensus statement on preliminary classification for definite antiphospholipid syndrome. Arthritis Rheum 42:1309–1311CrossRefPubMed Wilson WA, Gharavi AE, Koike T et al (1999) International consensus statement on preliminary classification for definite antiphospholipid syndrome. Arthritis Rheum 42:1309–1311CrossRefPubMed
7.
go back to reference Bernabo JG, Zoruba D, Metta S, Salomon E, Juarez MA (1986) Gangrene de pie y occlusion de los grandes vasos de la pierna secundarias a lupus eritematoso sistemico con vasculitis. Medicina (B Aires) 46:209–212 Bernabo JG, Zoruba D, Metta S, Salomon E, Juarez MA (1986) Gangrene de pie y occlusion de los grandes vasos de la pierna secundarias a lupus eritematoso sistemico con vasculitis. Medicina (B Aires) 46:209–212
8.
go back to reference Dubois EL, Tuffanelli DL (1964) Clinical manifestations of systemic lupus erythematosus. Computer analysis of 520 cases. JAMA 190:104–111PubMed Dubois EL, Tuffanelli DL (1964) Clinical manifestations of systemic lupus erythematosus. Computer analysis of 520 cases. JAMA 190:104–111PubMed
9.
go back to reference Goldberger E, Elder RC, Schwartz RA, Phillips PE (1992) Vasculitis in the antiphospholipid syndrome. Arthritis Rheum 35:569–572PubMed Goldberger E, Elder RC, Schwartz RA, Phillips PE (1992) Vasculitis in the antiphospholipid syndrome. Arthritis Rheum 35:569–572PubMed
10.
go back to reference Amital H, Levy Y, Langevitz P, Rubinow A, Shoenfeld Y (2002) Leg amputation–possible therapeutic role in catastrophic anti-phospholipid syndrome (CAPS)? Lupus 11:554 Amital H, Levy Y, Langevitz P, Rubinow A, Shoenfeld Y (2002) Leg amputation–possible therapeutic role in catastrophic anti-phospholipid syndrome (CAPS)? Lupus 11:554
11.
go back to reference Shetty VB, Rao S, Krishnamurthy PN, Shenoy VU (2001) Peripheral gangrene during infancy: a rare presentation of systemic lupus erythematosus. Arch Dis Child 85:335–336CrossRefPubMed Shetty VB, Rao S, Krishnamurthy PN, Shenoy VU (2001) Peripheral gangrene during infancy: a rare presentation of systemic lupus erythematosus. Arch Dis Child 85:335–336CrossRefPubMed
12.
go back to reference Yang SG, Kim KH, Park KC, Youn SW, Joh GY (1996) A case of systemic lupus erythematosus showing acute gangrenous change of fingertips (letter). Br J Dermatol 134:185–187PubMed Yang SG, Kim KH, Park KC, Youn SW, Joh GY (1996) A case of systemic lupus erythematosus showing acute gangrenous change of fingertips (letter). Br J Dermatol 134:185–187PubMed
13.
go back to reference Vocks E, Welcker M, Ring J (2000) Digital gangrene: a rare skin symptom in systemic lupus erythematosus. J Eur Acad Dermatol Venereol 14:419–421CrossRefPubMed Vocks E, Welcker M, Ring J (2000) Digital gangrene: a rare skin symptom in systemic lupus erythematosus. J Eur Acad Dermatol Venereol 14:419–421CrossRefPubMed
14.
go back to reference Gladstone DE, Prestrud AA, Styler MJ et al (2002) High dose cyclophosphamide for severe systemic lupus erythematosus. Lupus 11:405–410CrossRefPubMed Gladstone DE, Prestrud AA, Styler MJ et al (2002) High dose cyclophosphamide for severe systemic lupus erythematosus. Lupus 11:405–410CrossRefPubMed
15.
go back to reference Mittal G, Balakrishna C, Mangat G, Joshi VR (1999) ‘Sustained remission’ in a case of SLE following megadose cyclophosphamide. Lupus 8:77–80CrossRefPubMed Mittal G, Balakrishna C, Mangat G, Joshi VR (1999) ‘Sustained remission’ in a case of SLE following megadose cyclophosphamide. Lupus 8:77–80CrossRefPubMed
Metadata
Title
Arterial occlusion in systemic lupus erythematosus: a good prognostic sign?
Authors
Maria Cristina Baquero Teixeira da Rocha
Maria José Pereira Vilar
Eutília Andrade Medeiros Freire
Mittermayer Barreto Santiago
Publication date
01-12-2005
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 6/2005
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-005-1111-z

Other articles of this Issue 6/2005

Clinical Rheumatology 6/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.